These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17928161)

  • 1. Alzheimer's disease as copper deficiency.
    Klevay LM
    Med Hypotheses; 2008; 70(4):802-7. PubMed ID: 17928161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy.
    Rossi L; Squitti R; Calabrese L; Rotilio G; Rossini PM
    J Nutr Health Aging; 2007; 11(5):408-17. PubMed ID: 17657362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper in Alzheimer's disease: too much or too little?
    Quinn JF; Crane S; Harris C; Wadsworth TL
    Expert Rev Neurother; 2009 May; 9(5):631-7. PubMed ID: 19402774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease.
    Ojaimi J; Masters CL; McLean C; Opeskin K; McKelvie P; Byrne E
    Ann Neurol; 1999 Oct; 46(4):656-60. PubMed ID: 10514105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low vitamin K intakes in community-dwelling elders at an early stage of Alzheimer's disease.
    Presse N; Shatenstein B; Kergoat MJ; Ferland G
    J Am Diet Assoc; 2008 Dec; 108(12):2095-9. PubMed ID: 19027415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper imbalance and oxidative stress in neurodegeneration.
    Rossi L; Arciello M; Capo C; Rotilio G
    Ital J Biochem; 2006; 55(3-4):212-21. PubMed ID: 17274527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency.
    Stoltenberg M; Bush AI; Bach G; Smidt K; Larsen A; Rungby J; Lund S; Doering P; Danscher G
    Neuroscience; 2007 Dec; 150(2):357-69. PubMed ID: 17949919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
    Pardon MC; Sarmad S; Rattray I; Bates TE; Scullion GA; Marsden CA; Barrett DA; Lowe J; Kendall DA
    Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mercury and Alzheimer's disease].
    Mutter J; Naumann J; Schneider R; Walach H
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):528-38. PubMed ID: 17628833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
    Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgens and Alzheimer's disease.
    Drummond ES; Harvey AR; Martins RN
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):254-9. PubMed ID: 19373081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen treatment triggers cognitive impairment in Alzheimer's transgenic mice.
    Arendash GW; Cox AA; Mori T; Cracchiolo JR; Hensley KL; Roberts LJ
    Neuroreport; 2009 Aug; 20(12):1087-92. PubMed ID: 19543132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.
    Adlard PA; Cherny RA; Finkelstein DI; Gautier E; Robb E; Cortes M; Volitakis I; Liu X; Smith JP; Perez K; Laughton K; Li QX; Charman SA; Nicolazzo JA; Wilkins S; Deleva K; Lynch T; Kok G; Ritchie CW; Tanzi RE; Cappai R; Masters CL; Barnham KJ; Bush AI
    Neuron; 2008 Jul; 59(1):43-55. PubMed ID: 18614028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to the identification and quantitative elemental analysis of amyloid deposits--insights into the pathology of Alzheimer's disease.
    Rajendran R; Minqin R; Ynsa MD; Casadesus G; Smith MA; Perry G; Halliwell B; Watt F
    Biochem Biophys Res Commun; 2009 Apr; 382(1):91-5. PubMed ID: 19258010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
    Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ
    Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum modulates effects of beta amyloid(1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease.
    Drago D; Cavaliere A; Mascetra N; Ciavardelli D; di Ilio C; Zatta P; Sensi SL
    Rejuvenation Res; 2008 Oct; 11(5):861-71. PubMed ID: 18788899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
    J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.